These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21492043)

  • 21. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma.
    Henry CJ; McCaw DL; Turnquist SE; Tyler JW; Bravo L; Sheafor S; Straw RC; Dernell WS; Madewell BR; Jorgensen L; Scott MA; Higginbotham ML; Chun R
    Clin Cancer Res; 2003 Feb; 9(2):906-11. PubMed ID: 12576466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.
    Sternberg CN; Calabrò F; Pizzocaro G; Marini L; Schnetzer S; Sella A
    Cancer; 2001 Dec; 92(12):2993-8. PubMed ID: 11753976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.
    Dalbagni G; Russo P; Sheinfeld J; Mazumdar M; Tong W; Rabbani F; Donat MS; Herr HW; Sogani P; dePalma D; Bajorin D
    J Clin Oncol; 2002 Aug; 20(15):3193-8. PubMed ID: 12149290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder.
    Abbo AH; Jones DR; Masters AR; Stewart JC; Fourez L; Knapp DW
    J Vet Intern Med; 2010; 24(5):1124-30. PubMed ID: 20695986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs.
    Mutsaers AJ; Glickman NW; DeNicola DB; Widmer WR; Bonney PL; Hahn KA; Knapp DW
    J Am Vet Med Assoc; 2002 Jun; 220(12):1813-7. PubMed ID: 12092954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer.
    Knapp DW; Glickman NW; Mohammed SI; DeNicola DB; Widmer WR; Bonney PL; DeGortari AE
    Adv Exp Med Biol; 2002; 507():377-80. PubMed ID: 12664613
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs.
    Schmidt BR; Glickman NW; DeNicola DB; de Gortari AE; Knapp DW
    J Am Vet Med Assoc; 2001 Jun; 218(11):1783-6. PubMed ID: 11394830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open-label phase 1 dose-escalation clinical trial of a single intravenous administration of gemcitabine in dogs with advanced solid tumors.
    Marconato L; Finotello R; Bonfanti U; Dacasto M; Beatrice L; Pizzoni S; Leone VF; Balestra G; Furlanello T; Rohrer Bley C; Aresu L
    J Vet Intern Med; 2015; 29(2):620-5. PubMed ID: 25818216
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Byer B; Schlein LJ; Rose B; Séguin B
    Can J Vet Res; 2020 Apr; 84(2):115-123. PubMed ID: 32255906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma].
    Gunlusoy B; Arslan M; Vardar E; Degirmenci T; Kara C; Ceylan Y; Kozacıoğlu Z
    Actas Urol Esp; 2012 Oct; 36(9):515-20. PubMed ID: 22819345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases.
    Gustafson TL; Biller B
    J Am Anim Hosp Assoc; 2019; 55(5):243-248. PubMed ID: 31433219
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.
    Caffo O; Fellin G; Graffer U; Valduga F; Bolner A; Luciani L; Tomio L; Galligioni E
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1310-6. PubMed ID: 14630267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.
    Moore MJ; Tannock IF; Ernst DS; Huan S; Murray N
    J Clin Oncol; 1997 Dec; 15(12):3441-5. PubMed ID: 9396395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.
    Lorusso V; Crucitta E; Silvestris N; Rosati G; Manzione L; De Lena M; Palmeri S; Gebbia V; Mancarella S; Sobrero A; Pezzella G; Comella P; Mangiameli A; Muci D;
    Oncol Rep; 2005 Feb; 13(2):283-7. PubMed ID: 15643512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.
    Li J; Juliar B; Yiannoutsos C; Ansari R; Fox E; Fisch MJ; Einhorn LH; Sweeney CJ
    J Clin Oncol; 2005 Feb; 23(6):1185-91. PubMed ID: 15718315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
    Herman JM; Smith DC; Montie J; Hayman JA; Sullivan MA; Kent E; Griffith KA; Esper P; Sandler HM
    Urology; 2004 Jul; 64(1):69-73. PubMed ID: 15245938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial.
    Pectasides D; Glotsos J; Bountouroglou N; Kouloubinis A; Mitakidis N; Karvounis N; Ziras N; Athanassiou A
    Ann Oncol; 2002 Feb; 13(2):243-50. PubMed ID: 11886001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
    Mermershtain W; Cohen AD; Lazarev I; Grunwald M; Ariad S
    J Chemother; 2003 Oct; 15(5):510-1. PubMed ID: 14598945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
    Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
    J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004).
    Wilson HM; Chun R; Larson VS; Kurzman ID; Vail DM
    J Am Vet Med Assoc; 2007 Jul; 231(1):101-6. PubMed ID: 17605672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.